Quantcast
Viewing latest article 10
Browse Latest Browse All 59

New FDA Guidances for October 2019 and Upcoming Adcom Meetings

By Sheila Plant, PhD, MHS, RAC (US), Director, Regulatory Strategy at Cato Research

Special Interest Guidances/Information Date Posted
Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 – Draft Guidance 01 November 2019
Chronic Hepatitis D Virus Infection: Developing Drugs for Treatment Guidance for Industry – Draft Guidance 01 November 2019
Electronic Submission of IND Safety Reports Technical Conformance Guide : Guidance for Industry – Final Guidance 30 October 2019
Providing Regulatory Submissions in Electronic Format: IND Safety Reports: Guidance for Industry – Draft Guidance 30 October 2019
Type V DMFs for CDER-Led Combination Products Using Device Constituent Parts With Electronics or Software Guidance for Industry – Draft Guidance 28 October 2019
Breast Implants – Certain Labeling Recommendations to Improve Patient Communication: Draft Draft Guidance for Industry and Food and Drug Administration Staff – Draft Guidance 24 October 2019
Drug Products Labeled as Homeopathic Guidance for FDA Staff and Industry: Draft Revised Draft – Draft Guidance 24 October 2019
Postmarketing Studies and Clinical Trials—Implementation of Section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act Guidance for Industry – Draft Guidance 24 October 2019
Identification of Manufacturing Establishments in Applications Submitted to CBER and CDER Questions and Answers – Final Guidance 22 October 2019
Drug Master Files Guidance for Industry – Draft Guidance 18 October 2019
Prescription Drug User Fee Act Waivers, Reductions, and Refunds for Drug and Biological Products Guidance for Industry – Final Guidance 16 October 2019
Submitting Study Datasets for Vaccines to the Office of Vaccines Research and Review: Guidance for Industry; Technical Specifications Document – Final Guidance 15 October 2019
Coronary, Peripheral, and Neurovascular Guidewires – Performance Tests and Recommended Labeling: Guidance for Industry and Food and Drug Administration Staff – Final Guidance 10 October 2019
Intravascular Catheters, Wires, and Delivery Systems with Lubricious Coatings – Labeling Considerations: Guidance for Industry and Food and Drug Administration Staff – Final Guidance 10 October 2019
Investigational In Vitro Diagnostics in Oncology Trials: Streamlined Submission Process for Study Risk Determination Guidance for Industry – Final Guidance 09 October 2019
Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus: Guidance for Industry – Final Guidance 02 October 2019
Investigational Enzyme Replacement Therapy Products: Nonclinical Assessment: Guidance for Industry – Final Guidance 02 October 2019
Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion: Guidance for Industry – Final Guidance 30 September 2019
   
Upcoming Meetings (* = New)
  November 6-7, 2019: General Hospital and Personal Use Devices Panel of the Medical Devices Advisory Committee Meeting
  November 8, 2019: Vaccines and Related Biological Products Advisory Committee Meeting
  November 13, 2019: Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee Meeting
  November 13-14, 2019: Immunology Devices Panel of the Medical Devices Advisory Committee Meeting
* November 14, 2019: Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee Meeting
* Blood Products Advisory Committee November 22, 2019 Meeting

   Last updated: 05 November 2019


Viewing latest article 10
Browse Latest Browse All 59

Trending Articles